Pfizer and BioNTech ready to vaccinate 12-year-olds

The Food and Drug Administration should make the decision.

Pfizer and BioNTech have asked the US regulator to approve the use of their COVID-19 vaccine for 12-15-year-olds.

In the United States, this vaccine is allowed to be used by those who have reached the age of 16. According to Pfizer and BioNTec, clinical trials have proven that the vaccine is safe and effective for 12-15-year-olds.

The relevant decision should be made by the Food and Drug Administration (FDA). Janet Woodcock, the current head of the FDA, tweeted that the Agency would review the request “as quickly as possible” but could not predict how long the process would take.

Moderna and Johnson & Johnson are also testing their vaccines for 12-18-year-olds.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor